RxDoctor Payments Data

Michael Legeyt, MD

Hand Surgery · Bristol, CTNPI 1932133436

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (37.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Arthrex at 42.3% of the total. 2025 is the largest year on record at $1,519, 5.6 times the $273 reported in 2019.

$4,620in general payments, 2019–2025

Across 41 payments — averaging $112.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2K
  • Kairos Surgical Inc$2K
  • Stryker$334
  • Skeletal Dynamics Inc$154
  • Medtronic$124
  • Exactech, Inc.$107
  • plus $214 from 4 others

What the payments were for

  • Travel & lodging$1,75038%
  • Food & beverage$1,67036%
  • Education$1,20026%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex15$1,953
Kairos Surgical Inc10$1,734
Stryker5$334
Skeletal Dynamics Inc2$154
Medtronic1$124
Exactech, Inc.1$107
Acumed LLC2$88
Johnson & Johnson(2 entities)2$57
Vertex2$42
Bioventus LLC1$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,620 in reported general payments places this provider in the 70th percentile of 54 hand surgery providers in Connecticut.

See all hand surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$85,311
Medicare patients
221
Services billed
744

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisone46$193
Tramadol Hcl41$93
Meloxicam20$65

Paid to pharmacies, not to this prescriber.

Other hand surgery in Bristol

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →